(Q38042808)

27 August 2017

title

Multimodal treatment of esophageal cancer (English)

1 reference

27 August 2017

4

Christian Wittekind

1 reference

27 August 2017

Florian Lordick

1

1 reference

27 August 2017

Arnulf H Hölscher

series ordinal

2

1 reference

27 August 2017

Karen Haustermans

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

13 September 2012

1 reference

Langenbeck's Archives of Surgery

27 August 2017

published in

1 reference

27 August 2017

volume

398

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

177-187

1 reference

Oesophageal cancer and gastro-oesophageal reflux: what is the relationship?

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Symptoms in patients with adenocarcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Incidence of adenocarcinoma among patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Esophageal adenocarcinoma incidence: are we reaching the peak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Divergent trends for gastric cancer incidence by anatomical subsite in US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Limited additional value of positron emission tomography in staging oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Oesophageal cancer: how radical should surgery be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Neoadjuvant therapy for oesophagogastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Preoperative chemotherapy for resectable thoracic esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Current treatment approach to locally advanced esophageal cancer: is resection mandatory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Targeting the human EGFR family in esophagogastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Surgical Mortality in Patients With Esophageal Cancer: Development and Validation of a Simple Risk Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Squamous Cell Carcinoma of the Thoracic Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-1001-1

Preoperative lymph-node staging in gastrointestinal cancer--correlation between size and tumor stage

21 January 2018

1 reference

12 December 2020

Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome

1 reference

12 December 2020

Preoperative risk analysis--a reliable predictor of postoperative outcome after transthoracic esophagectomy?

1 reference

12 December 2020

Limited resection for early adenocarcinoma in Barrett's esophagus

1 reference

12 December 2020

Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer

1 reference

12 December 2020

Preoperative radiotherapy for esophageal carcinoma

1 reference

12 December 2020

[Cardia cancer: attempt at a therapeutically relevant classification]

1 reference

12 December 2020

Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center

1 reference

12 December 2020

1 reference

12 December 2020

Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy

1 reference

12 December 2020

Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas

1 reference

12 December 2020

Staging of oesophageal adenocarcinoma

1 reference

12 December 2020

Endosonographic Staging of Esophageal Cancer: A Review of Literature Results

1 reference

12 December 2020

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

12 December 2020

Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)

1 reference

12 December 2020

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

12 December 2020

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

12 December 2020

[Merendino procedure with preservation of the vagus for early carcinoma of the gastroesophageal junction]

1 reference

12 December 2020

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

12 December 2020

Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit

1 reference

12 December 2020

10.1007/S00423-012-1001-1

Identifiers

DOI

1 reference

27 August 2017

1 reference